title: Necroptosis inhibitors as therapeutic targets in inflammation mediated disorders - a review of the current literature and patents.
abstract: Recent studies have shown substantial interplay between the apoptosis and necroptosis pathways. Necroptosis, a form of programmed cell death, has been found to stimulate the immune system contributing to the pathophysiology of several inflammation-mediated disorders. Determining the contribution of necroptotic signaling pathways to inflammation may lead to the development of selective and specific molecular target implicated necroptosis inhibitors. Areas covered: This review summarizes the recently published and patented necroptosis inhibitors as therapeutic targets in inflammation-mediated disorders. The role of several necroptosis inhibitors, focusing on specific signaling molecules, was discussed with particular attention to inflammation-mediated disorders. Data was obtained from Espacenet®, WIPO®, USPTO® patent websites, and other relevant sources (2006-2016). Expert opinion: Necroptosis inhibitors hold promise for treatment of inflammation-mediated clinical conditions in which necroptotic cell death plays a major role. Although necroptosis inhibitors reviewed in this survey showed inhibitory effects against several inflammation-mediated disorders, only a few have passed to the stage of clinical testing and need extensive research for therapeutic practice. Revisiting the existing drugs and developing novel necroptosis inhibiting agents as well as understanding their mechanism are essential. A detailed study of necroptosis function in animal models of inflammation may provide us an alternative strategy for the development of drug-like necroptosis inhibitors.
authors: a College of Biomedical and Health Sciences , Konkuk University , Chungju , Republic of Korea.
authors: Spandana Rajendra
authors: SR
authors: Kopalli
authors: a College of Biomedical and Health Sciences , Konkuk University , Chungju , Republic of Korea.
authors: Tae-Bong
authors: TB
authors: Kang
authors: a College of Biomedical and Health Sciences , Konkuk University , Chungju , Republic of Korea.
authors: Sushruta
authors: S
authors: Koppula
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D004195:Disease Models, Animal; D015195:Drug Design; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000503:physiopathology; D018836:Inflammation Mediators / Q000378:metabolism; D009336:Necrosis / Q000188:drug therapy*; D010330:Patents as Topic; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D000893:Anti-Inflammatory Agents; D018836:Inflammation Mediators
keywords: Apoptosis; RIPK1; immune system; inflammation; necroptosis; reactive oxygen species